Anne Li May 6th, 2017
Some types of sarcomas elicit a greater immune response than others, which sheds light on how immunotherapy could be used for this connective-tissue cancer, according to a new study.Sarcomas — cancers of the connective tissues like muscles, joints, fat and bone — come in dozens of subtypes. Clinical trial results have been mixed when treating these diverse tumors with immunotherapy, a targeted therapeutic strategy that has success in other cancers.
See original article at: https://www.sciencedaily.com/releases/2017/05/170502112547.htm
